BRIEF-GSK's ViiV announces mid-stage results for HIV injection drugs
February 23, 2016 at 12:30 PM EST
* ViiV Healthcare announces phase II study results for first two drug, long-acting injectable regimen for HIV-1 treatment
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.